It is a pharma public limited company based in Na, Telangana, India, established in 1995.
1995 | Na, Telangana, India | ActiveMark Drugs Limited, a active public limited company, was established on 18 January 1995 in Na, Telangana, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24239TG1995PLC019228. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹6.00 M and a paid-up capital of ₹4.21 M.
It upholds a active non-compliant status. Its leadership includes Anandam Dyavanapally (Director), Rajalingam Dyavanapalli (Director). It holds ₹3.60 M open charges and no settled loans. It is based at N-1-192,Viveknagarchikkadpally Hyderabad, Na, Telangana.
U24239TG1995PLC019228
019228
18 January 1995
₹6.00 M
₹4.21 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Mark Drugs Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anandam Dyavanapally | Director | 18 Jan 1995 | Current |
| Rajalingam Dyavanapalli | Director | 18 Jan 1995 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Mark Drugs's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Mark Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹3,600,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Feb 1999 | Canara Bank | ₹1.80 M | Open |
| 22 Feb 1997 | Canara Bank | ₹1.80 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Mark Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Mark Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mark Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Canara Bank amounted to Rs. 1.80 M with Charge ID 90115779 was registered on 11 Feb 1999. was recorded as a recent event.
Progress on A charge with Canara Bank amounted to Rs. 1.80 M with Charge ID 90115443 was registered on 22 Feb 1997. was documented.
The activity Anandam Dyavanapally was appointed as a Director was appointed as a Director on 18 Jan 1995 & has been associated with this company since 30 years 11 months . was completed.
Rajalingam Dyavanapalli was appointed as a Director was appointed as a Director on 18 Jan 1995 & has been associated with this company since 30 years 11 months . was recorded as a recent event.
Progress on Mark Drugs Limited was registered on 18 Jan 1995 with Roc Hyderabad & aged 30 years 11 months as per MCA records. was documented.
The CIN of Mark Drugs Limited is U24239TG1995PLC019228.
Mark Drugs Limited is headquartered at N-1-192,Viveknagarchikkadpally Hyderabad, Na, Telangana.
Mark Drugs Limited was incorporated on 18 January 1995.
The current directors of Mark Drugs Limited are
The primary industry of Mark Drugs Limited is Pharma.
Mark Drugs Limited is unlisted.
The authorized capital of Mark Drugs Limited is ₹6.00 M, and the paid-up capital is ₹4.21 M.
The compliance status of Mark Drugs Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX